Entity Details

Primary name SERA_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO43175
EntryNameSERA_HUMAN
FullNameD-3-phosphoglycerate dehydrogenase
TaxID9606
Evidenceevidence at protein level
Length533
SequenceStatuscomplete
DateCreated1999-07-15
DateModified2021-06-02

Ontological Relatives

GenesPHGDH

GO terms

Show/Hide Table
GOName
GO:0004617 phosphoglycerate dehydrogenase activity
GO:0005829 cytosol
GO:0006541 glutamine metabolic process
GO:0006544 glycine metabolic process
GO:0006564 L-serine biosynthetic process
GO:0006566 threonine metabolic process
GO:0007420 brain development
GO:0009055 electron transfer activity
GO:0009448 gamma-aminobutyric acid metabolic process
GO:0010468 regulation of gene expression
GO:0019530 taurine metabolic process
GO:0021510 spinal cord development
GO:0021782 glial cell development
GO:0021915 neural tube development
GO:0030060 L-malate dehydrogenase activity
GO:0031175 neuron projection development
GO:0051287 NAD binding
GO:0070062 extracellular exosome
GO:0070314 G1 to G0 transition

Subcellular Location

Show/Hide Table

Domains

Show/Hide Table
DomainNameCategoryType
IPR006139 D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domainDomainDomain
IPR006140 D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domainDomainDomain
IPR006236 D-3-phosphoglycerate dehydrogenaseFamilyFamily
IPR029009 Allosteric substrate binding domain superfamilyFamilyHomologous superfamily
IPR029752 D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site 1SiteConserved site
IPR029753 D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved siteSiteConserved site
IPR036291 NAD(P)-binding domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
601815 OMIMPhosphoglycerate dehydrogenase deficiency (PHGDHD)An autosomal recessive inborn error of L-serine biosynthesis, clinically characterized by congenital microcephaly, psychomotor retardation, and seizures. The disease is caused by variants affecting the gene represented in this entry.
256520 OMIMNeu-Laxova syndrome 1 (NLS1)A lethal, autosomal recessive multiple malformation syndrome characterized by ichthyosis, marked intrauterine growth restriction, microcephaly, short neck, limb deformities, hypoplastic lungs, edema, and central nervous system anomalies including lissencephaly, cerebellar hypoplasia and/or abnormal/agenesis of the corpus callosum. Abnormal facial features include severe proptosis with ectropion, hypertelorism, micrognathia, flattened nose, and malformed ears. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00157 NADHDrugbanksmall molecule